Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit

Sputnik V is 91.4% Effective, Says Vaccine Developers

Russia’s Sputnik V vaccine is 91.4 per cent effective in protecting COVID-19 and has demonstrated 100 per cent efficacy against severe coronavirus cases, the vaccine’s developers said on Monday.
“The efficacy of the Sputnik V vaccine is 91.4 per cent, based on the final control point analysis of data obtained 21 days after administering the first dose,” Gamaleya Center and the Russian Direct Investment Fund (RDIF) said in a statement. The vaccine demonstrated 100 per cent efficacy against severe coronavirus cases, it added.
Based on the data obtained at the third control point, the Gamaleya Center will create a report that will be used to submit for accelerated registration of the Sputnik V vaccine in various countries, the statement said.
“The new data on efficacy of the Gamaleya Center vaccine is extremely encouraging. Today it has become obvious to everyone that the end of the pandemic is possible only after the mass vaccination of the entire global population,” Minister of Health of the Russian Federation Mikhail Murashko said.
In this regard, ensuring equal access to effective and safe vaccines, including the Sputnik V vaccine, for people in every country should be the goal of foreign regulatory bodies and international organizations, he added.
“Results the Sputnik V vaccine has demonstrated during the Phase III clinical trials support our confidence in its high efficacy and complete safety for health,” Gamaleya Center Director Alexander Ginsburg said.

Get Daily Prediction & Stocks Tips On Your Mobile